Q4, FY 2021 Results: Mytheresa Reports Another Quarter of Exceptional Net Sales Growth; Full FY 2021 Net Sales at €612.1 Million, a Growth of 36.2% Over Last Year and 61.5% Compared to Full FY 2019
MYT Netherlands Parent B.V. (MYTE) reported a 36.1% increase in net sales for Q4 FY21, reaching €162.4 million. Annual net sales grew by 36.2% to €612.1 million. Two-year growth shows remarkable resilience with 60.5% growth in Q4 FY21 compared to Q4 FY19. Adjusted EBITDA rose 55.2% to €54.9 million in FY21, with an adjusted EBITDA margin increasing to 9.0%. For FY22, the company anticipates GMV between €750-770 million and net sales from €680-700 million, showcasing sustained growth in the luxury market.
- Net sales increased by 36.1% year-over-year to €162.4 million in Q4 FY21.
- Full FY 2021 net sales grew by 36.2% to €612.1 million.
- Two-year net sales growth of 60.5% in Q4 FY21 compared to Q4 FY19.
- Adjusted EBITDA increased to €54.9 million, up 55.2% year-over-year.
- Adjusted EBITDA margin improved to 9.0% from 7.9% in FY 2020.
- Active customers rose by 38.0% to 671,000, with high first-time buyer growth.
- Q4 FY21 adjusted EBITDA decreased to €11.2 million from €15.1 million due to prior cost-saving measures.
- Adjusted net income fell to €7.6 million from €9.4 million in the prior year period.
-
Increase in net sales of
36.1% year-over-year to€162.4 million in Q4 FY21 and36.2% for full FY 2021 to€612.1 million -
Top-line strength evident by two-year net sales growth of
60.5% (Q4 FY21 vs. Q4 FY19) and full fiscal year net sales growth of61.5% (FY 2021 vs. FY 2019) -
Continued strong profitability with adjusted EBITDA for full FY 2021 of
€54.9 million , compared to the€35.4 million in FY 2020, representing a significant growth of55.2% -
Increase of adjusted EBITDA margin to
9.0% from7.9% in FY 2020 -
Confirmation of long-term GMV CAGR of
22% -25% with sustainable profitability levels at7% -9% Adjusted EBITDA. Full FY 2022 guidance for GMV at€750 -770 million and adjusted EBITDA margin in the upper half of the long-term range
Kliger continued, "Looking ahead, we will continue to deliver a superior customer experience and deepen our partnerships with the most coveted global brands. Given our strong financial position, excellent momentum with customer cohorts, and superior execution, we feel extremely confident to continue achieving strong results in fiscal year 2022.”
FINANCIAL HIGHLIGHTS FOR THE FOURTH QUARTER ENDED
-
Net sales increase of
36.1% year-over-year to€162.4 million -
Strong Gross margin of
47.7% , as compared to46.3% in the prior year period -
Adjusted EBITDA of
€11.2 million , as compared to€15.1 million in the prior year period, which was impacted by temporary cost saving measures put in place in Q4 FY 20 at the start of COVID, which were out of line with historic trends -
Adjusted net income of
€7.6 million , as compared to€9.4 million in the prior year period
FINANCIAL HIGHLIGHTS FOR THE TWELVE MONTHS ENDED
-
Net sales increase of
36.2% year-over-year to€612.1 million -
LTM Active customer growth at
38.0% with 671,000 active customers -
Stable gross margin of
46.9% , as compared to46.7% in FY 2020 -
Adjusted EBITDA of
€54.9 million , as compared to€35.4 million in the prior year period -
Adjusted EBITDA margin of
9.0% , as compared to7.9% in the prior year period -
Adjusted operating income of
€46.7 million , as compared to€27.5 million in the prior year period -
Adjusted net income of
€32.1 million , as compared to€19.3 million in the prior year period
RECENT BUSINESS HIGHLIGHTS
Continued Global Expansion:
-
Strong net sales growth across all geographies with +
36.1% vs. Q4 FY20 and +60.5% vs. Q4 FY19 -
Outstanding net sales growth in
the United States with +133.3% vs. Q4 FY20 as consumer demand jumped up -
High-impact Top Customers events in
Beijing atTRB Temple and inParis in collaboration with the Centre Pompidou
Strong Brand Partnerships:
-
Exclusive capsule collections and pre-launches in collaboration with
Alexander McQueen ,Loro Piana , Jacquemus, Missoni, Brunello Cucinelli,Roger Vivier , Valentino,Christian Louboutin and many more - Curated Platform Model developed as an evolution of the partnership approach to truly integrate operations with major brands for scale, replenishment and capital efficiency
-
First beauty Pop-Up in collaboration with Estée Lauder Companies featuring La Mer,
Frédéric Malle and By Killian
High-quality Customer Growth:
-
Growth of active customers by
38.0% year-over-year to 671,000 (LTM) - Record growth of first-time buyers in Q4 FY21 with 110,000 new customers
- Continued positive repurchase rates of new customer cohorts acquired in Q2 FY21 in Q4 FY21, as compared to Q2 FY20 in Q4 FY20
-
Strong growth of number of Top Customers with
64% as well as average net sales per Top Customer in Q4 FY21 -
New partnership with
Vestiaire Collective offering a unique resale service for Mytheresa’s high-end luxury customers
Consistent Strong Operational Performance:
-
Maintained business continuity across all operations with focus on health and well-being of all
Mytheresa employees as top priority -
Continued to have very high customer satisfaction with a Net Promoter Score of
85.6% in Q4 FY21 - Achieved strong gross profit margin based on high full-price sales and delivered stable operational cost margin trends in Q4 FY21 and for the full FY 2021
BUSINESS OUTLOOK
For the full fiscal year ending
-
GMV in the range of
€750 million to€770 million , representing a22% to25% growth -
Active customer growth of
22% to25% , enlarging the customer base to 820,000 to 845,000 active customers -
Net Sales at€680 million to€700 million -
Gross Profit at
€345 million to€355 million , representing a21% to24% growth -
Adjusted EBITDA margin at the upper half of the long-term range of
7% to9%
The foregoing forward-looking statements reflect Mytheresa’s expectations as of today's date. Given the number of risk factors, uncertainties and assumptions discussed below, actual results may differ materially. Gross Merchandise Value (GMV) means the total Euro value of orders processed. GMV is inclusive of merchandise value, shipping and duty. It is net of returns, value added taxes and cancellations. We view GMV as an operating metric.
CONFERENCE CALL AND WEBCAST INFORMATION
FORWARD LOOKING STATEMENTS
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements relating to the impact of the COVID-19 global pandemic; future sales, expenses, and profitability; future development and expected growth of our business and industry; our ability to execute our business model and our business strategy; having available sufficient cash and borrowing capacity to meet working capital, debt service and capital expenditure requirements for the next twelve months; and projected capital spending. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements are only predictions. Actual events or results may differ materially from those stated or implied by these forward-looking statements. In evaluating these statements and our prospects, you should carefully consider the factors set forth below.
We undertake no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.
The achievement or success of the matters covered by such forward-looking statements involves known and unknown risks, uncertainties and assumptions. If any such risks or uncertainties materialize or if any of the assumptions prove incorrect, our results could differ materially from the results expressed or implied by the forward-looking statements we make.
You should not rely upon forward-looking statements as predictions of future events. Forward-looking statements represent our management’s beliefs and assumptions only as of the date such statements are made.
Further information on these and other factors that could affect our financial results is included in filings we make with the
ABOUT NON-IFRS FINANCIAL MEASURES
We review a number of operating and financial metrics, including the following business and non-IFRS metrics, to evaluate our business, measure our performance, identify trends affecting our business, formulate business plans and make strategic decisions. We present Adjusted EBITDA, Adjusted Operating Income and Adjusted Net Income because they are frequently used by analysts, investors and other interested parties to evaluate companies in our industry. Further, we believe these measures are helpful in highlighting trends in our operating results, because they exclude the impact of items that are outside the control of management or not reflective of our ongoing operations and performance. Adjusted EBITDA, Adjusted Operating Income, and Adjusted Net Income have limitations, because they exclude certain types of expenses. We use Adjusted EBITDA, Adjusted Operating Income, Adjusted Net Income as supplemental information only. You are encouraged to evaluate each adjustment and the reasons we consider it appropriate for supplemental analysis.
Our non-IFRS financial measures include:
-
Adjusted EBITDA is a non-IFRS financial measure that we calculate as net income before finance expense (net), taxes, and depreciation and amortization, adjusted to exclude
U.S. sales tax expenditures temporarily borne by us through the fourth quarter of fiscal 2020, IPO preparation and transaction costs and share-based compensation expenses. -
Adjusted Operating Income is a non-IFRS financial measure that we calculate as operating income, adjusted to exclude
U.S. sales tax expenditures temporarily borne by us through the fourth quarter of fiscal 2020, any IPO preparation and transaction costs and share-based compensation expenses. -
Adjusted Net Income is a non-IFRS financial measure that we calculate as net income, adjusted to exclude
U.S. sales tax expenditures temporarily borne by us, finance expenses on our Shareholder Loans, IPO preparation and transaction costs, share-based compensation expenses and related income tax effects.
We are not able to forecast net income (loss) on a forward-looking basis without unreasonable efforts due to the high variability and difficulty in predicting certain items that affect net income (loss), including, but not limited to, Income taxes and Interest expense and, as a result, are unable to provide a reconciliation to forecasted Adjusted EBITDA.
ABOUT
For more information, please visit https://investors.mytheresa.com/.
Financial Results and Key Operating Metrics
(Amounts in € millions)
|
Three Months Ended |
|
Twelve Months Ended |
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change
|
|
|
|
|
|
Change
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) (unaudited) |
|
|
|
|
|
|
|
|
|
|
|
Active customer (LTM in thousands) |
486 |
|
671 |
|
|
|
486 |
|
671 |
|
|
Total orders shipped (LTM in thousands) |
1,092 |
|
1,505 |
|
|
|
1,092 |
|
1,505 |
|
|
Average order value (LTM) |
600 |
|
595 |
|
( |
|
600 |
|
595 |
|
( |
Net sales |
|
|
|
|
|
|
|
||||
Gross profit |
|
|
|
|
|
|
|
||||
Gross profit margin(1) |
|
|
140 BPs |
|
|
|
20 BPs |
||||
Adjusted EBITDA(2) |
|
|
( |
|
|
|
|
||||
Adjusted EBITDA margin(1) |
|
|
(570 BPs) |
|
|
|
110 BPs |
||||
Adjusted Operating Income(2) |
|
|
( |
|
|
|
|
||||
Adjusted Operating Income margin(1) |
|
|
(520 BPs) |
|
|
|
150 BPs |
||||
Adjusted Net Income(2) |
|
|
( |
|
|
|
|||||
Adjusted Net Income margin(1) |
|
|
(320 BPs) |
|
|
90 BPs |
(1) As a percentage of net sales.
(2) EBITDA, adjusted EBITDA, adjusted Operating Income, adjusted net income are measures not defined under IFRS. For further information about how we calculate these measures and limitations of its use, see below.
Financial Results and Key Operating Metrics
(Amounts in € millions)
The following are reconciliations of Adjusted EBITDA, Adjusted Operating Income, and Adjusted Net Income to their most directly comparable IFRS financial measures:
|
Three Months Ended |
|
Twelve Months Ended |
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change
|
|
|
|
|
|
Change
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) (unaudited) |
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
( |
|
|
|
|
|
( |
Finance expenses, net |
|
|
|
|
( |
|
|
|
|
|
( |
Income tax expense |
|
|
|
|
( |
|
|
|
|
|
|
Depreciation and amortization |
|
|
|
|
( |
|
|
|
|
|
|
thereof depreciation of right- of use assets |
|
|
|
|
( |
|
|
|
|
|
|
EBITDA |
|
|
|
|
( |
|
|
|
|
|
( |
|
|
|
|
|
( |
|
|
|
|
|
( |
IPO preparation and transaction costs(2) |
|
|
|
|
( |
|
|
|
|
|
|
IPO-related share-based compensation(3) |
|
|
|
|
N/A |
|
|
|
|
|
N/A |
Adjusted EBITDA |
|
|
|
|
( |
|
|
|
|
|
|
|
Three Months Ended |
|
Twelve Months Ended |
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change
|
|
|
|
|
|
Change
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) (unaudited) |
|
|
|
|
|
|
|
|
|
|
|
Operating Income |
|
|
( |
|
|
|
( |
||||
|
|
|
( |
|
|
|
( |
||||
IPO preparation and transaction costs(2) |
|
|
( |
|
|
|
|
||||
IPO-related share-based compensation(3) |
|
|
N/A |
|
|
|
N/A |
||||
Adjusted Operating Income |
|
|
( |
|
|
|
|
Financial Results and Key Operating Metrics
(Amounts in € millions)
|
Three Months Ended |
|
Twelve Months Ended |
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change
|
|
|
|
|
|
Change
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) (unaudited) |
|
|
|
|
|
|
|
|
|
|
|
Net Income |
|
|
|
|
( |
|
|
|
|
|
( |
|
|
|
|
|
( |
|
|
|
|
|
( |
IPO preparation and transaction costs(2) |
|
|
|
|
( |
|
|
|
|
|
|
IPO-related share-based compensation (3) |
|
|
|
|
N/A |
|
|
|
|
|
N/A |
Finance expenses on shareholder loans (4) |
|
|
|
|
( |
|
|
|
|
|
( |
Income tax effect(5) |
|
|
|
|
|
|
|
|
|
|
( |
Adjusted Net Income |
|
|
|
|
( |
|
|
|
|
|
|
(1) Represents expenses related to sales tax liabilities temporarily borne by us through the fourth quarter of fiscal 2020 in
(2) Represents non-recurring professional fees, including consulting, legal and accounting fees, related to this offering, which are classified within selling, general and administrative expenses.
(3) In FY21, with the effective IPO, certain key management personnel received a one-time granted share-based compensation with
(4) Our Adjusted Net Income excludes finance expenses associated with our Shareholder Loans, which we do not consider to be indicative of our core performance. We did not receive any cash proceeds under the Shareholder Loans, which originated as part of the
(5) Reflects adjustments to historical income tax expense to reflect changes in taxable income for each of the periods presented due to changes in finance expenses related to the Shareholder Loans, assuming a statutory tax rate of
Unaudited Condensed Consolidated Statements of Profit and Comprehensive Income
(Amounts in € thousands, except share and per share data)
|
|
Three Months Ended |
|
Twelve Months Ended |
||||
|
|
|
|
|
|
|
||
(in € thousands) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
119,271 |
|
162,368 |
|
449,487 |
|
612,096 |
Cost of sales, exclusive of depreciation and amortization |
|
(63,993) |
|
(84,939) |
|
(239,546) |
|
(325,053) |
Gross profit |
|
55,278 |
|
77,429 |
|
209,941 |
|
287,043 |
Shipping and payment cost |
|
(12,383) |
|
(19,535) |
|
(52,857) |
|
(71,466) |
Marketing expenses |
|
(13,198) |
|
(22,326) |
|
(62,507) |
|
(81,558) |
Selling, general and administrative expenses |
|
(14,632) |
|
(39,449) |
|
(66,427) |
|
(157,151) |
Depreciation and amortization |
|
(2,140) |
|
(2,125) |
|
(7,885) |
|
(8,232) |
Other expense (income), net |
|
525 |
|
(231) |
|
645 |
|
(799) |
Operating income |
|
13,450 |
|
(6,237) |
|
20,911 |
|
(32,162) |
Finance (expense) income, net |
|
387 |
|
324 |
|
(11,119) |
|
15,091 |
Income (loss) before income taxes |
|
13,837 |
|
(5,913) |
|
9,791 |
|
(17,070) |
Income tax (expense) income |
|
(2,777) |
|
(2,070) |
|
(3,441) |
|
(15,534) |
Net income (loss) |
|
11,060 |
|
(7,983) |
|
6,350 |
|
(32,604) |
Cash Flow Hedge |
|
335 |
|
43 |
|
- |
|
- |
Income Taxes related to Cash Flow Hedge |
|
(92) |
|
20 |
|
- |
|
- |
Foreign currency translation |
|
(14) |
|
- |
|
4,730 |
|
- |
Other comprehensive income (loss) |
|
229 |
|
63 |
|
4,730 |
|
- |
Comprehensive income (loss) |
|
11,289 |
|
(7,920) |
|
11,080 |
|
(32,604) |
|
|
|
|
|
|
|
|
|
Basic and diluted earnings per share |
€ |
0.16 |
€ |
(0.09) |
|
0.09 |
€ |
(0.42) |
Weighted average ordinary shares outstanding (basic and diluted) |
|
70,190,687 |
|
86,321,840 |
|
70,190,687 |
|
77,360,088 |
Unaudited Condensed Consolidated Statements of Financial Position
(Amounts in € thousands)
(in € thousands) |
|
|
||
Assets |
||||
Non-current assets |
||||
Intangible assets and goodwill |
154,966 |
155,611 |
||
Property and equipment, net |
|
9,570 |
|
8,810 |
Right-of-use assets |
19,001 |
14,009 |
||
Total non-current assets |
183,537 |
178,430 |
||
Current assets |
|
|
||
Inventories |
|
169,131 |
|
247,054 |
Trade and other receivables |
4,815 |
5,030 |
||
Other assets |
|
18,950 |
|
14,667 |
Cash and cash equivalents |
9,367 |
76,760 |
||
Total current assets |
|
202,263 |
|
343,510 |
Total assets |
385,800 |
521,941 |
||
|
|
|||
Shareholders’ equity and liabilities |
|
|
||
Subscribed capital |
1 |
1 |
||
Capital reserve |
|
91,008 |
|
444,951 |
Accumulated Deficit |
(28,234) |
(60,837) |
||
Other comprehensive income |
|
1,602 |
|
1,602 |
Total shareholders’ equity |
64,377 |
385,718 |
||
|
|
|||
Non-current liabilities |
|
|
|
|
Shareholder Loans |
191,194 |
- |
||
Other liabilities |
|
5,905 |
|
- |
Tax liabilities |
3,853 |
14,293 |
||
Provisions |
|
582 |
|
717 |
Lease liabilities |
13,928 |
8,786 |
||
Deferred tax liabilities, net |
|
1,130 |
|
2,308 |
Total non-current liabilities |
216,592 |
26,104 |
||
Current liabilities |
|
|
|
|
Liabilities to banks |
10,000 |
- |
||
Lease liabilities |
|
5,787 |
|
5,361 |
Contract liabilities |
6,758 |
10,975 |
||
Trade and other payables |
|
36,158 |
|
43,558 |
Other liabilities |
46,128 |
50,225 |
||
Total current liabilities |
|
104,831 |
|
110,118 |
Total liabilities |
321,422 |
136,223 |
||
Total shareholders’ equity and liabilities |
|
385,800 |
|
521,941 |
Unaudited Condensed Consolidated Statements of Changes in Equity
(Amounts in € thousands)
(in € thousands) |
|
Subscribed capital |
|
Capital reserve |
|
Accumulated deficit |
|
Foreign currency translation reserve |
|
Total shareholders’ equity |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
Balance as of |
|
72 |
|
148,960 |
|
(34,584) |
|
(3,128) |
|
111,320 |
Net income |
|
- |
|
- |
|
6,350 |
|
- |
|
6,350 |
Other comprehensive income |
|
- |
|
- |
|
- |
|
4,730 |
|
4,730 |
Comprehensive income |
|
- |
|
- |
|
6,350 |
|
4,730 |
|
11,080 |
Distribution |
|
- |
|
(191,207) |
|
- |
|
- |
|
(191,207) |
Contribution |
|
- |
|
96,938 |
|
- |
|
- |
|
96,938 |
Legal Reorganization |
|
(71) |
|
36,252 |
|
- |
|
- |
|
36,180 |
Share-based compensation |
|
- |
|
65 |
|
- |
|
- |
|
65 |
Balance as of |
|
1 |
|
91,008 |
|
(28,234) |
|
1,602 |
|
64,377 |
|
|
|
|
|
|
|
|
|
|
|
Balance as of |
|
1 |
|
91,008 |
|
(28,234) |
|
1,602 |
|
64,377 |
Net loss |
|
- |
|
- |
|
(32,604) |
|
- |
|
(32,604) |
Other comprehensive income |
|
- |
|
- |
|
- |
|
- |
|
- |
Comprehensive loss |
|
- |
|
- |
|
(32,604) |
|
- |
|
(32,604) |
Capital increase - initial public offering |
|
- |
|
283,224 |
|
- |
|
- |
|
283,224 |
IPO related transaction costs |
|
- |
|
(4,550) |
|
- |
|
- |
|
(4,550) |
Share-based compensation |
|
- |
|
75,270 |
|
- |
|
- |
|
75,270 |
Balance as of |
|
1 |
|
444,951 |
|
(60,837) |
|
1,602 |
|
385,718 |
Unaudited Condensed Consolidated Statements of Cash Flows
(Amounts in € thousands)
|
Year ended |
|||
(in € thousands) |
|
2020 |
|
2021 |
|
|
|
|
|
Net income (loss) |
|
6,350 |
|
(32,604) |
Adjustments for |
|
|
|
|
Depreciation and amortization |
|
7,885 |
|
8,232 |
Finance (income) expense, net |
|
11,119 |
|
(15,091) |
Share-based compensation |
|
65 |
|
75,270 |
Income tax expense |
|
3,441 |
|
15,534 |
Change in operating assets and liabilities |
|
|
|
|
(Decrease) increase in provisions |
|
(200) |
|
135 |
Increase in inventories |
|
(33,097) |
|
(77,922) |
(Increase) decrease in trade and other receivables |
|
833 |
|
(215) |
Decrease (increase) in other assets |
|
(10,510) |
|
4,281 |
(Decrease) increase in other liabilities |
|
17,894 |
|
(1,809) |
Increase in contract liabilities |
|
2,210 |
|
4,217 |
Increase (decrease) in trade and other payables |
|
6,745 |
|
7,400 |
Income taxes paid |
|
(2,176) |
|
(3,915) |
Net cash provided by (used in) operating activities |
|
10,559 |
|
(16,486) |
Expenditure for property and equipment and intangible assets |
|
(2,420) |
|
(2,934) |
Proceeds from sale of property and equipment |
|
- |
|
40 |
Net cash (used in) investing activities |
|
(2,420) |
|
(2,894) |
Interest paid |
|
(2,973) |
|
(4,257) |
Proceeds from bank liabilities |
|
90,750 |
|
64,990 |
Repayment of liabilities from banks |
|
(84,399) |
|
(74,990) |
Repayment of Shareholder loan |
|
- |
|
(171,827) |
Proceeds from capital increase |
|
- |
|
283,224 |
IPO preparation and transaction costs |
|
- |
|
(4,550) |
Lease payments |
|
(4,256) |
|
(5,800) |
Net cash (used in) provided by financing activities |
|
(878) |
|
86,790 |
Net increase (decrease) in cash and cash equivalents |
|
7,261 |
|
67,411 |
Cash and cash equivalents at the beginning of the period |
|
2,120 |
|
9,367 |
Effects of exchange rate changes on cash and cash equivalents |
|
(14) |
|
(18) |
Cash and cash equivalents at end of the period |
|
9,367 |
|
76,760 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210914005235/en/
Investor Relations Contacts
Solebury Trout
+1-800-929-7167
investors@mytheresa.com
Media Contacts for public relations
mobile: +49 152 54725178
phone: +49 89 127695-236
email: sandra.romano@mytheresa.com
Media Contacts for business press
mobile: +49 152 38297355
phone: +49 89 127695-1358
email: alberto.fragoso@mytheresa.com
phone: +1 201 341-0211 / +1 646 750-7235
email: ted.mchugh@edelman.com
email: nicole.briguet@edelman.com
mobile: +49 162 4909624
phone: +49 22182828111
email: ruediger.assion@edelman.com
Source:
FAQ
What were the key financial results for MYTE in Q4 FY21?
How did MYTE perform in FY2021 compared to FY2020?
What is MYTE's outlook for FY2022?
How many active customers did MYTE have in FY21?